Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1155979.RAfS3dg3vt7G95-mNCjf5xcpizOoWKwyTPX3y91yoZHJM130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1155979.RAfS3dg3vt7G95-mNCjf5xcpizOoWKwyTPX3y91yoZHJM130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1155979.RAfS3dg3vt7G95-mNCjf5xcpizOoWKwyTPX3y91yoZHJM130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1155979.RAfS3dg3vt7G95-mNCjf5xcpizOoWKwyTPX3y91yoZHJM130_provenance.
- NP1155979.RAfS3dg3vt7G95-mNCjf5xcpizOoWKwyTPX3y91yoZHJM130_assertion description "[Therefore, KRAS mutation testing should be performed in all individuals with the advanced CRC in order to identify the patients who will not respond to the monoclonal EGFR antibody inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1155979.RAfS3dg3vt7G95-mNCjf5xcpizOoWKwyTPX3y91yoZHJM130_provenance.
- NP1155979.RAfS3dg3vt7G95-mNCjf5xcpizOoWKwyTPX3y91yoZHJM130_assertion evidence source_evidence_literature NP1155979.RAfS3dg3vt7G95-mNCjf5xcpizOoWKwyTPX3y91yoZHJM130_provenance.
- NP1155979.RAfS3dg3vt7G95-mNCjf5xcpizOoWKwyTPX3y91yoZHJM130_assertion SIO_000772 24534449 NP1155979.RAfS3dg3vt7G95-mNCjf5xcpizOoWKwyTPX3y91yoZHJM130_provenance.
- NP1155979.RAfS3dg3vt7G95-mNCjf5xcpizOoWKwyTPX3y91yoZHJM130_assertion wasDerivedFrom befree-2016 NP1155979.RAfS3dg3vt7G95-mNCjf5xcpizOoWKwyTPX3y91yoZHJM130_provenance.
- NP1155979.RAfS3dg3vt7G95-mNCjf5xcpizOoWKwyTPX3y91yoZHJM130_assertion wasGeneratedBy ECO_0000203 NP1155979.RAfS3dg3vt7G95-mNCjf5xcpizOoWKwyTPX3y91yoZHJM130_provenance.
- befree-2016 importedOn "2016-02-19" NP1155979.RAfS3dg3vt7G95-mNCjf5xcpizOoWKwyTPX3y91yoZHJM130_provenance.